Core Scientific Inc CORZ.OQ CORZ.O is expected to show a fall in quarterly revenue when it reports results on August 6 for the period ending June 30 2025
The Dover Delaware-based company is expected to report a 42.2% decrease in revenue to $81.588 million from $141.1 million a year ago, according to the mean estimate from 13 analysts, based on LSEG data.
LSEG's mean analyst estimate for Core Scientific Inc is for a loss of 8 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy," 9 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Core Scientific Inc is $18.00, about 21.8% above its last closing price of $14.08
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | -0.12 | -0.11 | 1.25 | Beat | 1,279.2 |
Dec. 31 2025 | -0.08 | -0.08 | -0.60 | Missed | -616.6 |
Sep. 30 2024 | -0.10 | -0.09 | -1.17 | Missed | -1,179.5 |
Jun. 30 2024 | 0.02 | 0.03 | -4.51 | Missed | -14,193.7 |
Mar. 31 2024 | 0.13 | 0.13 | 0.16 | Beat | 23.1 |
|
This summary was machine generated August 6 at 21:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)